140 related articles for article (PubMed ID: 10944975)
1. [Control of cholesterolemia in Spain, 2000. A tool for cardiovascular prevention].
Plaza Pérez I; Villar Alvarez F; Mata López P; Pérez Jiménez F; Maiquez Galán A; Casasnovas Lenguas JA; Banegas Banegas JR; Tomás Abadal L; Rodríguez Artalejo F; Gil López E
Rev Esp Cardiol; 2000 Jun; 53(6):815-37. PubMed ID: 10944975
[TBL] [Abstract][Full Text] [Related]
2. [Cholesterolemia control in Spain, 2000: a tool for cardiovascular disease prevention].
Plaza Pérez I; Villar Alvarez F; Mata López P; Pérez Jiménez F; Maiquez Galán A; Casasnovas Lenguas JA; Banegas Banegas JR; Tomás Abadal L; Rodríguez Artalejo F; Gil López E
Rev Clin Esp; 2000 Sep; 200(9):494-515. PubMed ID: 11111397
[TBL] [Abstract][Full Text] [Related]
3. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
4. [Recommendations for the control of cholesterolemia in Spain].
Villar Alvarez F; Mata López P; Plaza Pérez I; Pérez Jiménez F; Maiques Galán A; Casasnovas Lenguas JA; Banegas Banegas JR; Abadal LT; Rodríguez Artalejo F; Gil López E
Rev Esp Salud Publica; 2000; 74(5-6):457-74. PubMed ID: 11217236
[TBL] [Abstract][Full Text] [Related]
5. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
Bruckert E; Ferrières J
Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
[TBL] [Abstract][Full Text] [Related]
6. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
[TBL] [Abstract][Full Text] [Related]
7. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
[TBL] [Abstract][Full Text] [Related]
8. [Active interventions in hypercholesteroloemia patients with high cardivascular risk in primary care].
Tárraga López PJ; Garcia-Norro Herreros FJ; Tárraga Marcos L; Solera Albero J; González López E; Ruiz García A; Pallarés Carratalá V; Castro Navarro JL; Alins Presas J; Panisello Royo JM
Nutr Hosp; 2015 May; 31(5):2261-8. PubMed ID: 25929402
[TBL] [Abstract][Full Text] [Related]
9. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
10. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
11. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
[TBL] [Abstract][Full Text] [Related]
12. Influence of Gender and Cardiovascular Risk on the Control of Low-density Lipoprotein in a Population From Extremadura.
Félix-Redondo FJ; Lozano-Mera L; Mostaza JM; Saénz P; Fernández-Berges D; Buitrago F
Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1184-6. PubMed ID: 26603088
[No Abstract] [Full Text] [Related]
13. [Active interventions in hypercholesteroloemia patients with high cardiovascular risk in primary care; estudio ESPROCOL].
Tárraga López PJ; García-Norro Herreros FJ; Tárraga Marcos L; Solera Albero J; González López E; Ruiz García A; Pallarés Carratalá V; Castro Navarro JL; Alins Presas J; Panisello Royo JM
Nutr Hosp; 2015 Jun; 31(6):2727-34. PubMed ID: 26040387
[TBL] [Abstract][Full Text] [Related]
14. [Study of the prevalence of hypercholesterolemia in Extremadura].
Gimeno Ortiz A; Jiménez Romano R; Vázquez Domínguez JA; Rueda Muñoz C
Rev Sanid Hig Publica (Madr); 1993; 67(4):267-78. PubMed ID: 7732293
[TBL] [Abstract][Full Text] [Related]
15. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
16. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
Agabiti Rosei E; Salvetti M
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain.
de la Sierra A; Pintó X; Guijarro C; Miranda JL; Callejo D; Cuervo J; Subirà R; Rubio M
Adv Ther; 2015 Oct; 32(10):944-61. PubMed ID: 26499178
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
19. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
Brath H; Wascher TC; Kästenbauer T; Toplak H
MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of cardiovascular diseases among hypercholesterolemic Japanese with a low dose of pravastatin.
Nakamura H;
Atheroscler Suppl; 2007 Aug; 8(2):13-7. PubMed ID: 17586102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
